Howard University Telehealth Training Center
HUTTC Home | About | News | Current Projects | Past Projects | On-Demand Videos and Podcasts

4. Issues of Ethnopharmacology in HIV Management

Tropism Incidence Among Different HIV-1 Clades

Patients who are infected with HIV-1 from clades other than clade B (the clade to which the overwhelming majority of infections in the Americas and Western Europe belong) may have different incidences of the predominance or emergence of CXCR4-tropic virus compared with patients infected with clade B HIV. US clinicians managing patients who have emigrated from areas where non-clade-B infections predominate need to be aware that such patients may have HIV disease from a different clade than most of the patients that they manage. This can have practical implications for developing the most appropriate and effective treatment plan. For example, antiretroviral-naive patients infected with certain non-clade-B viruses may not be good candidates for treatment with a CCR5 antagonist. The paragraphs that follow will outline some of the variable patterns of tropism in non-clade-B infections.

A study conducted among 68 antiretroviral-naive pregnant Ugandan women analyzed both the clades to which their viruses belonged and the incidence of both R5 and X4 viruses. The investigators reported that patients infected with clade D HIV-1 had an unusually high prevalence of X4 and dual/mixed virus, with 36% of patients infected with clade D virus having X4 virus vs 0% of patients infected with either clade A or clade A/D viruses (Figure 2). [Huang 2007]

Figure 2. High Prevalence of X4 Virus in Patients with Clade D HIV-1 Infection

Phenotypic Tropism Test Result (%)

Clade A
(n = 33)

Clade A/D
(n = 10)

Clade D
(n = 25)

R5 HIV-1

100

100

100

X4 HIV-1

0

0

36

Clade C HIV-1 is one of the most widely distributed variants in Eastern and Southern Africa (including Ethiopia, Somalia, Kenya, South Africa, and other countries) and India, and among patients infected with this variant the prevalence X4 virus is low. In fact, several earlier studies reported that no X4 virus was identified among antiretroviral-naive patients infected with clade C HIV-1. Genetic variation in clade C virus reduces the likelihood of X4 virus emerging in antiretroviral-naive patients; this is the reverse of what happens in subtype D infection. [Cecilia 2000, Björndal 1999, Tscherning 1998]

More recently, however, Johnston and colleagues reported that X4 and dual/mixed viruses occur with increasing frequency at virologic failure; this is similar to the pattern of X4 virus occurrence in patients infected with clade B HIV-1. [Johnston 2003] Therefore, practitioners need to investigate in a culturally and linguistically sensitive manner the racial and geographic background of their patients to fully understand the context in which they will be developing an antiretroviral management approach for each individual.

« BACK

NEXT »